157 related articles for article (PubMed ID: 20379713)
1. Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR.
Ito S; Kodera Y; Mochizuki Y; Kojima T; Nakanishi H; Yamamura Y
World J Surg; 2010 Sep; 34(9):2083-9. PubMed ID: 20379713
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
[TBL] [Abstract][Full Text] [Related]
4. A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC).
Ueda Y; Fujimura T; Kinami S; Hirono Y; Yamaguchi A; Naitoh H; Tani T; Kaji M; Yamagishi H; Miwa K;
Jpn J Clin Oncol; 2006 Aug; 36(8):519-22. PubMed ID: 16803844
[TBL] [Abstract][Full Text] [Related]
5. Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial.
Yoshikawa T; Terashima M; Mizusawa J; Nunobe S; Nishida Y; Yamada T; Kaji M; Fukushima N; Hato S; Choda Y; Yabusaki H; Yoshida K; Ito S; Takeno A; Yasuda T; Kawachi Y; Katayama H; Fukuda H; Boku N; Sano T; Sasako M
Lancet Gastroenterol Hepatol; 2019 Mar; 4(3):208-216. PubMed ID: 30679107
[TBL] [Abstract][Full Text] [Related]
6. Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma.
Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Yamamura Y; Fujiwara M; Hibi K; Ito K; Akiyama S; Tatematsu M; Nakao A
Jpn J Clin Oncol; 2004 Sep; 34(9):525-31. PubMed ID: 15466826
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
[TBL] [Abstract][Full Text] [Related]
8. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
9. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma.
Kodera Y; Nakanishi H; Ito S; Yamamura Y; Kanemitsu Y; Shimizu Y; Hirai T; Yasui K; Kato T; Tatematsu M
Ann Surg; 2002 Apr; 235(4):499-506. PubMed ID: 11923605
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
Ishigami H; Kitayama J; Kaisaki S; Hidemura A; Kato M; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Nagawa H
Ann Oncol; 2010 Jan; 21(1):67-70. PubMed ID: 19605503
[TBL] [Abstract][Full Text] [Related]
11. [A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen].
Takashima T; Nakata B; Komoto M; Nomura S; Sawada T; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1041-4. PubMed ID: 16044970
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients.
Tamura N; Iinuma H; Takada T
Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
14. [An effective treatment by chemotherapy with S-1 and CDDP intraperitoneal administration for the peritoneal dissemination of gastric cancer--a case report].
Kadono M; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2442-4. PubMed ID: 21224600
[TBL] [Abstract][Full Text] [Related]
15. Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors?
Hasbahceci M; Malya FU; Kunduz E; Guzel M; Unver N; Akcakaya A
Ann R Coll Surg Engl; 2018 Apr; 100(4):257-266. PubMed ID: 29543051
[TBL] [Abstract][Full Text] [Related]
16. Quantitative detection of disseminated cancer cells in the greater omentum of gastric carcinoma patients with real-time RT-PCR: a comparison with peritoneal lavage cytology.
Kodera Y; Nakanishi H; Ito S; Yamamura Y; Kanemitsu Y; Shimizu Y; Hirai T; Yasui K; Kato T; Tatematsu M
Gastric Cancer; 2002; 5(2):69-76. PubMed ID: 12111581
[TBL] [Abstract][Full Text] [Related]
17. Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients.
Ito S; Nakanishi H; Kodera Y; Mochizuki Y; Tatematsu M; Yamamura Y
Br J Cancer; 2005 Oct; 93(9):986-92. PubMed ID: 16205696
[TBL] [Abstract][Full Text] [Related]
18. Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
Takahashi R; Ohashi M; Kano Y; Ida S; Kumagai K; Nunobe S; Chin K; Yamaguchi K; Nagino M; Sano T; Hiki N
Gastric Cancer; 2019 Nov; 22(6):1256-1262. PubMed ID: 30877407
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR.
Sakakura C; Takemura M; Hagiwara A; Shimomura K; Miyagawa K; Nakashima S; Yoshikawa T; Takagi T; Kin S; Nakase Y; Fujiyama J; Hayasizaki Y; Okazaki Y; Yamagishi H
Br J Cancer; 2004 Feb; 90(3):665-71. PubMed ID: 14760382
[TBL] [Abstract][Full Text] [Related]
20. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
